Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Urticaria
ADR ID BADD_A04469
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.06      Urticarias
10.01.06.001      Urticaria
23      Skin and subcutaneous tissue disorders
23.04      Angioedema and urticaria
23.04.02      Urticarias
23.04.02.001      Urticaria
Description A disorder characterized by an itchy skin eruption characterized by wheals with pale interiors and well-defined red margins. [CTCAE] A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. [MeSH]
MedDRA Code 10046735
MeSH ID D014581
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute allergic urticaria | Acute urticaria | Allergic urticaria | Erythema urticarial | Generalised urticarial | Generalised urticarial rash | Histamine-like rash | Hives | Nettle rash | Other specified urticaria | Pharmacological urticaria | Rash urticaria-like | Rash urticarial | Subcutaneous urticaria | Unspecified urticaria | Urticaria | Urticaria acute | Urticaria aggravated | Urticaria NOS | Urticaria subcutaneous | Urticaria, unspecified | Urticarial | Urticarial rash | Urticarial symptom | Urticated rash | Urtication | Welts | Wheals | Generalized urticaria | Urticaria generalised | Urticaria drug-induced | Urticaria localised | Urticaria localized | Generalized urticarial rash | Urticaria recurrent | Generalised urticaria | Atopic urticaria | Urticarias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01858Propagermanium--
BADD_D01860Propantheline--
BADD_D01861Propantheline bromide--
BADD_D01864Propofol0.001947%
BADD_D01867Propranolol--
BADD_D01868Propranolol hydrochloride--
BADD_D01869Propylthiouracil--
BADD_D01872Protriptyline--
BADD_D01873Protriptyline hydrochloride--
BADD_D01876Pseudoephedrine--
BADD_D01880Pyrazinamide--
BADD_D01881Pyridostigmine0.002125%
BADD_D01886Pyrimethamine0.000312%
BADD_D01892Quinaprilat0.006163%
BADD_D01893Quinidine gluconate--
BADD_D01894Quinidine sulfate--
BADD_D01895Quinine--
BADD_D01897Quinine sulfate--
BADD_D01898Rabeprazole0.000963%
BADD_D01903Raloxifene0.000226%
BADD_D01906Raltegravir potassium--
BADD_D01909Ramipril0.002145%
BADD_D01910Ramiprilat--
BADD_D01913Ranitidine--
BADD_D01915Ranolazine--
BADD_D01916Rasagiline mesylate--
BADD_D01918Raxibacumab--
BADD_D01919Reboxetine--
BADD_D01920Refludan--
BADD_D01921Regadenoson0.000888%
The 35th Page    First    Pre   35 36 37 38 39    Next   Last    Total 45 Pages
ADReCS-Target
ADR Term Drug Name Target